Deadline: 5 January 2025
The U.S. Embassy and Consulates in India is pleased to announce that Nexus, a premier business incubator hosted at the American Center in New Delhi, is currently accepting applications for its 20th cohort which will begin a nine-week training program on February 2, 2025.
The Nexus cohort program provides an invaluable opportunity for 15-Indian startup companies to receive specialized training from Indian and American experts to sharpen their value propositions, define their target markets, get market feedback on product/technology and create milestones to bring their companies to the market. This latest cohort will also explore the influence of artificial intelligence on startup ventures and the importance of mental health for entrepreneurs.
Following the initial nine-week training program up to four companies will be invited to remain at Nexus for more in-depth support. These companies will be given full access to incubator facilities and network for up to an additional eight months. During this time, the Nexus team of experts will also work with them to take their companies to the next level by helping them get their products to market, grow their customer and revenue bases and, if appropriate, obtain funding to scale their operations.
To deliver training for Nexus’ 20th cohort, the U.S. Embassy is partnering with the Global Training and Development Institute (GTDI) at the University of Connecticut (UConn). The program is funded by a grant from the U.S. Embassy in New Delhi and the U.S. Department of State. GTDI works together with the Daigle Labs at UConn’s School of Business to provide participants from across India the perspectives and the critical tools for exploring the development of new and emerging ventures. The aim of the partnership is to enable sustainable community development while promoting the cultural and economic relationships between the United States and India.
What they are looking for?
- They are pretty wide open. However, due to time to market issues, startups in the pharmaceutical/drug discovery space will probably not be a good fit with Nexus.
- They look for companies that have a clear value proposition and quantifiable benefits. USUALLY, this will translate into companies with a business to business (B2B) model, but not always.
- Lastly, applicants must have an innovative component. If you have the latest e-commerce site, social media platform or are looking to start a franchise of an existing service, that’s great! However, Nexus is probably not the best place for you.
For more information, visit U.S. Embassy and Consulates in India.
